InvestigationalInvestigational
Amycretin
Also known as:Novo Nordisk amycretin
- Class
- Investigational
- Route
- SC injection or oral in trials
- Frequency
- Weekly injection or daily oral in trials
- GLP-1 relevance
- Yes
How it works
Unimolecular GLP-1 + amylin receptor agonist
Approved & studied uses
Obesity / type 2 diabetes pipeline
Regulatory status
Investigational
Safety notes
No approved dosing.
Sources
Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.